Pay in 4 interest-free payments of $10.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Molecular Weight: 504
and induces caspase-dependent apoptosis in leukemic cells but not in normal immature CD34+ cells
LY2784544 shows anti-proliferative activity in JAK2 V617F-driven cells with an IC50 of 68 nM
PubMed PMID: 31757294
RKI-1447 - CAS# 1342278-01-6 Catalog No.:M60415-2S Molecular Weight: 504RKI 1447, CAS No. 1342278 01 6, is a potent inhibitor of the Rho associated ROCK kinases with anti invasive and antitumor activities in breast cancer. RKI 1447 is a Type I kinase inhibitor that binds the ATP binding site through interactions with the hinge region and the DFG motif. RKI 1447 suppressed phosphorylation of the ROCK substrates MLC 2 and MYPT 1 in human cancer cells. Product information CAS Number: 1342278 01 6 Molecular Weight: 326. 37